Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Alzheimer Disease × Methods × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Conditions

Breast Neoplasms 43 Neoplasms 34 Colorectal Neoplasms 23 Lung Neoplasms 22 Uterine Cervical Neoplasms 13 Prostatic Neoplasms 13 Motor Activity 12 Colonic Neoplasms 10 Rectal Neoplasms 8 Pancreatic Neoplasms 8 Lymphoma 8 Carcinoma, Non-Small-Cell Lung 8 Anxiety Disorders 8 Obesity 7 Hematologic Neoplasms 7 Depression 7 Vulvar Neoplasms 6 Melanoma 6 Head and Neck Neoplasms 6 Endometrial Neoplasms 6 Breast Carcinoma In Situ 6 Urinary Bladder Neoplasms 5 Pain 5 Ovarian Neoplasms 4 Neoplasm Metastasis 4 Leukemia, Myeloid, Acute 4 Hematopoietic and Lymphoid System Neoplasm 4 Fatigue 4 Carcinoma, Ovarian Epithelial 4 Vaginal Neoplasms 3

Interventions

Dexamethasone 3 XENP 1595 2 Electroencephalography 2 pomalidomide 1 ixazomib 1 birtamimab 1 UE2343 1 Telemedicine 1 Tablets 1 Standard of Care 1 Rosiglitazone 1 Propofol 1 Positron-Emission Tomography 1 Methods 1 Melphalan 1 Mass Screening 1 Magnetic Resonance Imaging 1 Lysine Acetyltransferase 5 1 Hypnosis 1 Hormones 1 Exercise 1 Ethanol 1 Donepezil 1 Cyclophosphamide 1 Control Groups 1 Calcium Dobesilate 1 Bortezomib 1 Blood Specimen Collection 1 Amyloid 1 7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07332377 2026-03-18

PsyMINT

Virginia Commonwealth University

Phase NA Recruiting

Agnosia, Alzheimer Disease, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡